Castle Biosciences CSTL Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's common stock, shares issued (in shares)?
- Castle Biosciences (CSTL) reported common stock, shares issued (in shares) of $30.3M in Q1 2026.
- How has Castle Biosciences's common stock, shares issued (in shares) changed year-over-year?
- Castle Biosciences's common stock, shares issued (in shares) increased by 5.0% year-over-year, from $28.84M to $30.3M.
- What is the long-term trend for Castle Biosciences's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Castle Biosciences's common stock, shares issued (in shares) has grown at a 3.7% compound annual growth rate (CAGR), from $24.81M to $29.69M.